Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 5NETWORK 2NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

Amplified Fragment Length Polymorphism Analysis 21Gene Expression Profiling 17Microarray Analysis 13Immunohistochemistry 12Polymerase Chain Reaction 9Specimen Handling 6Psychiatric Rehabilitation 6Reverse Transcriptase Polymerase Chain Reaction 5Mass Spectrometry 4Flow Cytometry 4Biopsy 4Molecular Diagnostic Techniques 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Immunologic Techniques 3Genetic Linkage 3DNA Methylation 3Cytogenetic Analysis 3Chromatography, High Pressure Liquid 3Watchful Waiting 2Therapeutics 2Leukapheresis 2In Situ Hybridization, Fluorescence 2Immunoenzyme Techniques 2Genetic Testing 2Early Intervention, Educational 2Cyclophosphamide 2Carboplatin 2Bleeding Time 2hepatitis B hyperimmune globulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Observational × Fluorescent Antibody Technique × Clear all
NCT00897065 2013-07-10

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

National Cancer Institute (NCI)

Unknown
957 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡